Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

v3.5.0.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Condensed Consolidated Statements of Operations and Comprehensive Loss        
Collaboration revenue       $ 317
Operating expenses:        
Research and development $ 11,584 $ 6,866 $ 29,374 16,030
General and administrative 2,633 1,598 7,544 3,418
Total operating expenses 14,217 8,464 36,918 19,448
Loss from operations (14,217) (8,464) (36,918) (19,131)
Other income (expense), net 48   140 2
Net loss and comprehensive loss (14,169) (8,464) (36,778) (19,129)
Accrued dividends on preferred stock (121) (1,243) (3,681) (3,690)
Net loss applicable to common stockholders $ (14,290) $ (9,707) $ (40,459) $ (22,819)
Net loss per share attributable to common stockholders - basic and diluted $ (0.65) $ (4.51) $ (4.44) $ (12.21)
Weighted-average number of common shares used in net loss per share applicable to common stockholders - basic and diluted 22,012,743 2,150,274 9,110,993 1,868,182